B
Amgen Inc. AMGN
$275.85 $3.441.26% NASDAQ
Recommendation
Prev Close
$275.85
Volume
2,193
Avg Vol (90D)
3,156,158
Market Cap
$148.33B
Dividend & Yield
$9.26(3.36%)
52-Week Range
$253.30 - $346.85
P/E (TTM)
25.17
EPS (TTM)
$10.96
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
3 Biotech Giants Gaining From U.S. Sales and Policy Shifts
5/2/2025 - MarketBeat
Amgen (AMGN) Faces Transition Amid Key Drugs' Market Exclusivity Loss AMGN Stock News
5/20/2025 - GuruFocus
Amgen assumed with a Neutral at Guggenheim
5/20/2025 - The Fly
Strive Asset Management LLC Makes New $652,000 Investment in Amgen Inc. (NASDAQ:AMGN)
5/20/2025 - MarketBeat
Tema Etfs LLC Makes New Investment in Amgen Inc. (NASDAQ:AMGN)
5/20/2025 - MarketBeat
Tidal Investments LLC Boosts Stock Position in Amgen Inc. (NASDAQ:AMGN)
5/20/2025 - Ticker Report
Buy These 3 Healthcare Mutual Funds to Strengthen Your Portfolio
5/20/2025 - Zacks Investment Research
Amgen (NASDAQ:AMGN) Upgraded at StockNews.com
5/20/2025 - MarketBeat
Amgen vs Bristol Myers: Which Biotech Giant Has Better Prospects?
5/19/2025 - Zacks Investment Research
Notable ETF Inflow Detected - QLD, ADBE, AMGN, VRTX
5/19/2025 - ETF Channel
Novo Nordisk Shares Dip 3% on Sudden CEO Transition Announcement
5/19/2025 - Zacks Investment Research
St. Clair Advisors LLC Takes $730,000 Position in Amgen Inc. (NASDAQ:AMGN)
5/19/2025 - Ticker Report
Improve Your Retirement Income with These 3 Top-Ranked Dividend Stocks
5/19/2025 - Zacks Investment Research
Silvercrest Asset Management Group LLC Has $30.94 Million Stock Holdings in Amgen Inc. (NASDAQ:AMGN)
5/19/2025 - MarketBeat
2 Safe-and-Steady Stocks Worth Your Attention and 1 to Avoid
5/19/2025 - StockStory Articles
Sig Brokerage LP Buys New Stake in Amgen Inc. (NASDAQ:AMGN)
5/18/2025 - MarketBeat
Sen. Tommy Tuberville Sells Amgen Inc. (NASDAQ:AMGN) Stock
5/18/2025 - MarketBeat
Polar Asset Management Partners Inc. Acquires Shares of 95,000 Amgen Inc. (NASDAQ:AMGN)
5/17/2025 - MarketBeat
Pathstone Holdings LLC Sells 6,280 Shares of Amgen Inc. (NASDAQ:AMGN)
5/17/2025 - MarketBeat
AMGEN TO PRESENT AT THE 2025 RBC CAPITAL MARKETS GLOBAL HEALTHCARE CONFERENCE
5/16/2025 - GuruFocus
Amgen Inc (AMGN) to Present at 2025 RBC Capital Markets Global Healthcare Conference AMGN ...
5/16/2025 - GuruFocus
AMGEN TO PRESENT AT THE 2025 RBC CAPITAL MARKETS GLOBAL HEALTHCARE CONFERENCE AMGN Stock News
5/16/2025 - GuruFocus
AMGEN TO PRESENT AT THE 2025 RBC CAPITAL MARKETS GLOBAL HEALTHCARE CONFERENCE
5/16/2025 - PR Newswire
Eli Lilly pulls ahead of Novo in obesity drug gold rush as new players crowd in
5/16/2025 - Invezz News
Earnings Miss? Amgen’s Dividend Still a Bright Spot
2/5/2025 - MarketBeat
Income Statement
Total Revenue (TTM)
$34.13B
EBITDA (TTM)
$16.28B
EBIT (TTM)
$11.02B
Net Income (TTM)
$5.93B
Balance Sheet
Total Assets (Q)
$89.37B
Total Debt (Q)
$57.38B
Total Liabilities (Q)
$83.16B
Book Value Per Share (Q)
$11.54
Cash Flow
Cash from Operations (TTM)
$12.19B
Cash from Investing (TTM)
-$1.28B
Cash from Financing (TTM)
-$11.81B
Net Change in Cash (TTM)
-$898.00M
Filings
Filing Date
Friday, May 2, 2025
Period Date
Monday, March 31, 2025
Next Filing
Week of Aug 4 and 8 (est)
Price History
Loading...
Beta
0.37
7-Day Total Return
4.68%
30-Day Total Return
-3.93%
60-Day Total Return
-10.15%
90-Day Total Return
6.18%
Year to Date Total Return
8.20%
1-Year Total Return
-9.47%
2-Year Total Return
31.10%
3-Year Total Return
22.59%
5-Year Total Return
41.45%
52-week Low
Dec 19, 2024 - $253.30
52-week High
Jul 25, 2024 - $346.85
Valuation
Market Cap
$148.33B - Large Cap
Enterprise Value
$196.90B
Price/Sales (TTM)
4.37
Price/Book (Q)
23.90
Dividends and Shares
Shares Outstanding
541.00M
Dividend Per Share (Most Recent)
$2.38
Dividend Per Share (TTM)
$9.26
Corporate Info
Website
www.amgen.com
Phone Number
805 447 1000
Address
One Amgen Center Drive
Thousand Oaks, CA 91320-1799
Country
United States
Year Founded
1980
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company’s principal products include Enbrel for the treatment of rheumatoid arthritis, plaque... more
NASDAQ 05/19/2025 4:00PM Eastern Quotes delayed